OriGene Technologies, Inc. Acquires Marligen Biosciences, Inc.

Bookmark and Share

Acquisition Strengthens Gene Centric Product Portfolio

ROCKVILLE, Md., Oct. 19 /PRNewswire/ -- OriGene Technologies, Inc. today announced the acquisition of Marligen Biosciences, Inc., a provider of cutting-edge multiplex assays for the Luminex xMAP(R) platform for protein and gene expression profiling assays and testing services, and DNA and RNA purification kits. The acquisition reinforces OriGene’s leading position in the bio-medical research industry by expanding the scope of its gene centric toolbox portfolio and further represents another step in OriGene’s aggressive growth plan.

The acquisition will enhance OriGene’s gene centric product portfolio to include new assay panels and custom assays for drug discovery. Leveraging OriGene’s high throughput monoclonal antibody production capability, OriGene intends to complete its development of high quality assay panels and custom assays for researchers that will dramatically hasten and increase efficiencies for drug discovery. OriGene’s mammalian cell expressed proteins maintain the most authentic protein structure, post-translational modifications, and functions.

With Marligen’s assay development expertise and a strong menu of kits and reagents, and the complementary assets and strengths of OriGene’s product line, OriGene will provide a complete product solution to fully address the needs of drug discovery researchers. By acquiring Marligen, OriGene has increased its critical mass and enhanced its competitive strength for creating a gene centric product line which researchers can use to accelerate drug discovery and cellular analysis. All of Marligen’s key talent will be retained by OriGene at its new state-of-art research facility in Rockville, Maryland.

About OriGene

OriGene Technologies, Inc., is a gene centric life sciences tool company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene’s novel product line includes the world’s largest cDNA and shRNA clone collections, over 5,000 purified human proteins, high quality monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is committed to its mission to be “Your Gene Company”, in supplying everything a researcher would need for gene based research. For more information, visit www.origene.com.

SOURCE OriGene Technologies, Inc.

MORE ON THIS TOPIC